UPDATED Sep 21, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €4.20 | 0% | -30.0% | €117.6m | €12.30 | 14.8 | 98.0% | n/a | ||
ARGX | €868.00 | 0.02% | 37.5% | €54.3b | €1,026.58 | 36.3 | 26.8% | n/a | ||
UCB | €212.10 | 0.8% | 2.7% | €40.4b | €285.00 | 18.4 | 13.8% | 0.7% | ||
CYAD | €0.25 | 10.6% | -18.6% | €11.2m | n/a | 13.5 | n/a | n/a | ||
OXUR | €0.0018 | -30.8% | -91.8% | €253.3k | n/a | -0.1 | n/a | n/a | ||
TUB | €179.80 | 0.7% | 7.0% | €8.0b | €286.00 | 81.3 | n/a | 0.6% | ||
BIOS | €0.002 | 0% | -16.7% | €1.3m | n/a | -0.3 | n/a | n/a |